Barclays Initiates Coverage On Edwards Lifesciences with Overweight Rating, Announces Price Target of $110
Edwards Lifesciences Says FDA Approves AUTUS Size-Adjustable Valve, Surgical Pulmonary Valve Designed For Pediatric Patients With Congenital Heart Disease